A detailed history of Kensington Investment Counsel, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Kensington Investment Counsel, LLC holds 17,145 shares of TECH stock, worth $1.22 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
17,145
Previous 14,090 21.68%
Holding current value
$1.22 Million
Previous $1.09 Million 10.95%
% of portfolio
0.55%
Previous 0.57%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$65.98 - $77.09 $201,568 - $235,509
3,055 Added 21.68%
17,145 $1.21 Million
Q4 2023

Feb 15, 2024

BUY
$52.83 - $78.22 $2,113 - $3,128
40 Added 0.28%
14,090 $1.09 Million
Q3 2023

Nov 09, 2023

BUY
$67.52 - $89.42 $33,354 - $44,173
494 Added 3.64%
14,050 $956,000
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $3,245 - $3,783
-44 Reduced 0.32%
13,556 $1.11 Million
Q1 2023

May 11, 2023

SELL
$71.62 - $86.62 $90,527 - $109,487
-1,264 Reduced 8.5%
13,600 $1.01 Million
Q4 2022

Feb 15, 2023

BUY
$80.67 - $352.29 $899,309 - $3.93 Million
11,148 Added 300.0%
14,864 $1.23 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $392,730 - $544,671
1,390 Added 59.76%
3,716 $1.06 Million
Q2 2022

Jul 15, 2022

SELL
$322.67 - $449.65 $11,938 - $16,637
-37 Reduced 1.57%
2,326 $806,000
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $836,147 - $1.15 Million
2,363 New
2,363 $1.02 Million
Q1 2022

May 13, 2022

SELL
$353.85 - $487.79 $1.71 Million - $2.36 Million
-4,846 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $295,129 - $339,713
647 Added 15.41%
4,846 $2.51 Million
Q2 2021

Aug 13, 2021

BUY
$387.35 - $450.26 $40,284 - $46,827
104 Added 2.54%
4,199 $1.89 Million
Q1 2021

May 13, 2021

BUY
$314.62 - $411.0 $101,936 - $133,164
324 Added 8.59%
4,095 $1.56 Million
Q4 2020

Feb 16, 2021

BUY
$246.9 - $321.87 $931,059 - $1.21 Million
3,771 New
3,771 $1.2 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Kensington Investment Counsel, LLC Portfolio

Follow Kensington Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kensington Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kensington Investment Counsel, LLC with notifications on news.